Javier C Angulo
Overview
Explore the profile of Javier C Angulo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
122
Citations
1138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Larrinaga G, Redrado M, Loizaga-Iriarte A, Perez-Fernandez A, Santos-Martin A, Angulo J, et al.
Cancer Immunol Immunother
. 2025 Jan;
74(2):53.
PMID: 39751643
Clear cell renal cell carcinoma (ccRCC) is one of the most challenging neoplasms because of its phenotypic variability and intratumoral heterogeneity. Because of its variability, ccRCC is a good test...
2.
Emaldi M, Rey-Iborra E, Marin A, Mosteiro L, Lecumberri D, Oyjord T, et al.
Oncoimmunology
. 2024 Dec;
13(1):2419686.
PMID: 39621555
Immune checkpoint inhibitors in combination with tyrosine kinase inhibitors (TKIs) are improving the response rates of advanced renal cancer patients. However, many treated patients do not respond, making novel immune...
3.
Tellez C, Diego R, Szczesniewski J, Giammo A, Gonzalez-Enguita C, Schonburg S, et al.
J Clin Med
. 2024 Aug;
13(16).
PMID: 39200769
: Male stress urinary incontinence (SUI) after surgical treatment of benign prostatic enlargement (BPE) is an infrequent but dreadful complication and constitutes a therapeutic challenge. The efficacy and safety of...
4.
Angulo J, Larrinaga G, Lecumberri D, Iturregui A, Solano-Iturri J, Lawrie C, et al.
Cancers (Basel)
. 2024 Aug;
16(16).
PMID: 39199559
(1) Objective: To develop a clinically useful nomogram that may provide a more individualized and accurate estimation of cancer-specific survival (CSS) for patients with clear-cell (CC) metastatic renal cell carcinoma...
5.
Armesto M, Nemours S, Arestin M, Bernal I, Solano-Iturri J, Manrique M, et al.
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 38999991
Sunitinib has greatly improved the survival of clear cell renal cell carcinoma (ccRCC) patients in recent years. However, 20-30% of treated patients do not respond. To identify miRNAs and genes...
6.
Angulo J
J Clin Med
. 2024 Jun;
13(11).
PMID: 38892801
Unfortunately, prostate cancer treatment is not free of complications [...].
7.
Angulo J, Giammo A, Queissert F, Schonburg S, Gonzalez-Enguita C, Gonsior A, et al.
BJUI Compass
. 2024 Apr;
5(4):506-514.
PMID: 38633825
Objectives: This study aimed to compare the effectiveness and safety of the adjustable trans-obturator male system (ATOMS®) to treat post-prostatectomy incontinence (PPI) in radiated patients compared with non-radiated patients, using...
8.
Sterling J, Simhan J, Flynn B, Rusilko P, Franca W, Ramirez E, et al.
J Urol
. 2024 Feb;
211(4):607.
PMID: 38382012
No abstract available.
9.
Larrinaga G, Valdivia A, Arrieta-Aguirre I, Solano-Iturri J, Ugalde-Olano A, Loizaga-Iriarte A, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38338778
Renal cell carcinoma (RCC) ranks among the most prevalent malignancies in Western countries, marked by its notable heterogeneity, which contributes to an unpredictable clinical trajectory. The insufficiency of dependable biomarkers...
10.
Sterling J, Simhan J, Flynn B, Rusilko P, Franca W, Ramirez E, et al.
J Urol
. 2024 Jan;
211(4):596-604.
PMID: 38275201
Purpose: The treatment of urethral stenosis after a combination of prostatectomy and radiation therapy for prostate cancer is understudied. We evaluate the clinical and patient-related outcomes after dorsal onlay buccal...